Literature DB >> 33353459

Increased Hepatic Fat Content in Patients with Resistance to Thyroid Hormone Beta.

Carolina Chaves1, Eveline Bruinstroop2,3, Samuel Refetoff4, Paul M Yen3,5,6, João Anselmo1.   

Abstract

Background: Thyroid hormone (TH) has important functions in controlling hepatic lipid metabolism. Individuals with resistance to thyroid hormone beta (RTHβ) who harbor mutations in the THRB gene experience loss-of-function of thyroid hormone receptor beta (TRβ), which is the predominant TR isoform expressed in the liver. We hypothesized that individuals with RTHβ may have increased hepatic steatosis.
Methods: Controlled attenuation parameter (CAP) was assessed in individuals harboring the R243Q mutation of the THRB gene (n = 21) and in their wild-type (WT) first-degree relatives (n = 22) using the ultrasound-based transient elastography (TE) device (FibroScan). All participants belonged to the same family, lived on the same small island, and were therefore exposed to similar environmental conditions. CAP measurements and blood samples were obtained after an overnight fast. The observers were blinded to the status of the patients.
Results: The hepatic fat content was increased in RTHβ individuals compared with their WT relatives (CAP values of 263 ± 21 and 218.7 ± 43 dB/m, respectively, p = 0.007). The CAP values correlated with age and body mass index (BMI) (age: r = 0.55, p = 0.011; BMI: r = 0.51, p = 0.022) in the WT first-degree relatives but not in RTHβ individuals, suggesting that the defect in TRβ signaling was predominant over the effects of age and obesity. Circulating free fatty acid levels were significantly higher in RTHβ individuals (0.29 ± 0.033 vs. 0.17 ± 0.025 mmol/L, p = 0.02). There was no evidence of insulin resistance evaluated by the homeostatic model assessment of insulin resistance in both groups studied. Conclusions: Our findings provide evidence that impairments in intrahepatic TRβ signaling due to mutations of the THRB gene can lead to hepatic steatosis, which emphasizes the influence of TH in the liver metabolism of lipids and provides a rationale for the development TRβ-selective thyromimetics. Consequently, new molecules with a very high TRβ affinity and hepatic selectivity have been developed for the treatment of lipid-associated hepatic disorders, particularly nonalcoholic fatty liver disease.

Entities:  

Keywords:  hepatic steatosis; resistance to thyroid hormone beta; thyroid hormones; transient elastography

Mesh:

Substances:

Year:  2021        PMID: 33353459      PMCID: PMC8290309          DOI: 10.1089/thy.2020.0651

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.506


  34 in total

1.  Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

Authors:  Rohit Loomba; Nicholas Schork; Chi-Hua Chen; Ricki Bettencourt; Ana Bhatt; Brandon Ang; Phirum Nguyen; Carolyn Hernandez; Lisa Richards; Joanie Salotti; Steven Lin; Ekihiro Seki; Karen E Nelson; Claude B Sirlin; David Brenner
Journal:  Gastroenterology       Date:  2015-08-20       Impact factor: 22.682

2.  Non-alcoholic fatty liver disease across the spectrum of hypothyroidism.

Authors:  Goh Eun Chung; Donghee Kim; Won Kim; Jeong Yoon Yim; Min Jung Park; Yoon Jun Kim; Jung-Hwan Yoon; Hyo-Suk Lee
Journal:  J Hepatol       Date:  2012-03-14       Impact factor: 25.083

3.  Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea.

Authors:  Young Eun Chon; Kyu Sik Jung; Kwang Joon Kim; Dong Jin Joo; Beom Kyung Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Seung Up Kim
Journal:  Dig Dis Sci       Date:  2014-08-14       Impact factor: 3.199

4.  MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.

Authors:  Jurgen Henk Runge; Loek Pieter Smits; Joanne Verheij; Annekatrien Depla; Sjoerd Douwe Kuiken; Bert Cornelis Baak; Aart Johannes Nederveen; Ulrich Beuers; Jaap Stoker
Journal:  Radiology       Date:  2017-09-15       Impact factor: 11.105

Review 5.  Thyroid Hormone Signaling and the Liver.

Authors:  Megan J Ritter; Izuki Amano; Anthony N Hollenberg
Journal:  Hepatology       Date:  2020-08       Impact factor: 17.425

Review 6.  Non-invasive evaluation of liver fibrosis using transient elastography.

Authors:  Laurent Castera; Xavier Forns; Alfredo Alberti
Journal:  J Hepatol       Date:  2008-02-26       Impact factor: 25.083

7.  Pathogenesis of hypothyroidism-induced NAFLD is driven by intra- and extrahepatic mechanisms.

Authors:  Giuseppe Ferrandino; Rachel R Kaspari; Olga Spadaro; Andrea Reyna-Neyra; Rachel J Perry; Rebecca Cardone; Richard G Kibbey; Gerald I Shulman; Vishwa Deep Dixit; Nancy Carrasco
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-10       Impact factor: 11.205

8.  Thyroid hormone-related regulation of gene expression in human fatty liver.

Authors:  Jussi Pihlajamäki; Tanner Boes; Eun-Young Kim; Farrell Dearie; Brian W Kim; Joshua Schroeder; Edward Mun; Imad Nasser; Peter J Park; Antonio C Bianco; Allison B Goldfine; Mary Elizabeth Patti
Journal:  J Clin Endocrinol Metab       Date:  2009-06-23       Impact factor: 5.958

Review 9.  Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management.

Authors:  Thomas Marjot; Ahmad Moolla; Jeremy F Cobbold; Leanne Hodson; Jeremy W Tomlinson
Journal:  Endocr Rev       Date:  2020-01-01       Impact factor: 19.871

Review 10.  Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists.

Authors:  Rohit A Sinha; Eveline Bruinstroop; Brijesh K Singh; Paul M Yen
Journal:  Thyroid       Date:  2019-09       Impact factor: 6.568

View more
  3 in total

Review 1.  Targeting Thyroid Hormone/Thyroid Hormone Receptor Axis: An Attractive Therapy Strategy in Liver Diseases.

Authors:  Qianyu Tang; Min Zeng; Linxi Chen; Nian Fu
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

Review 2.  Influence of Altered Thyroid Hormone Mechanisms in the Progression of Metabolic Dysfunction Associated with Fatty Liver Disease (MAFLD): A Systematic Review.

Authors:  Rafael Aguiar Marschner; Fernanda Arenhardt; Rafael Teixeira Ribeiro; Simone Magagnin Wajner
Journal:  Metabolites       Date:  2022-07-22

3.  Resistance to Thyroid Hormones: A Case-Series Study.

Authors:  Rossella Cannarella; Marco Musmeci; Vincenzo Garofalo; Tiziana A Timpanaro; Guido Leone; Manuela Caruso; Paolo E Maltese; Rosita A Condorelli; Sandro La Vignera; Aldo E Calogero
Journal:  Int J Mol Sci       Date:  2022-09-24       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.